A randomized trial of symptom-based management in Japanese patients with COPD

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global Strategy for the Diagnosis, Management and Prevention of COPD2017 Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed March 29, 2017
   Google Scholar
• Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD4th ed2013 Available from: https://www.jrs.or.jp/modules/guidelines/index.php?content_id=1Accessed March 29, 2017
   Google Scholar
• National Institute for Health and Clinical ExcellenceNICE clinical guideline 101 Available from: http://www.nice.org.uk/nicemedia/live/13029/49397/49397Accessed May 5, 2016
   Google Scholar
• MagnussenHWatzHKirstenAStepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationaleRespir Med2014108459359924477080
   PubMed Web of Science ®Google Scholar
• NanniniLJPoolePMilanSJHolmesRNormansellRCombined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201311CD003794
   PubMed Web of Science ®Google Scholar
• KarnerCChongJPoolePTiotropium versus placebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20127CD009285
   PubMed Web of Science ®Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2009180874175019644045
   PubMed Web of Science ®Google Scholar
• SilerTMKerwinESousaARDonaldAAliRChurchAEfficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: results of two randomized studiesRespir Med201510991155116326117292
   PubMed Web of Science ®Google Scholar
• SaitoTTakedaAHashimotoKKobayashiAHayamizuTHaganGWTriple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial – evaluation of Airway sGaw after treatment with tripLEInt J Chron Obstruct Pulmon Dis2015102393240426604737
   PubMed Web of Science ®Google Scholar
• PerngDWWuCCSuKCLeeYCPerngRPTaoCWAdditive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroidsRespirology200611559860216916333
   PubMed Web of Science ®Google Scholar
• FrithPAThompsonPJRatnavadivelRGlycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study, a randomised controlled trialThorax201570651952725841237
   PubMed Web of Science ®Google Scholar
• CazzolaMMateraMGTriple combinations in chronic obstructive pulmonary disease – is three better than two?Expert Opin Pharmacother201415172475247825327264
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLFergussonDTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
   PubMed Web of Science ®Google Scholar
• ShortPMWilliamsonPAElderDHJLipworthSIWSchembriSLipworthBJThe impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPDChest20121411818621799028
   PubMed Web of Science ®Google Scholar
• JonesPWKatoMFujimotoKCOPD Symptom Based Management and Optimize Treatment Strategy in Japan (The COSMOS-J Trial)Am J Respir Crit Care Med2016193A7906
   Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• BetsuyakuTKatoMFujimotoKA study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011Int J Chron Obstruct Pulmon Dis2013845345924124358
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• LeidyNKWilcoxTKJonesPWStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
   PubMed Web of Science ®Google Scholar
• LeidyNKMurrayLTMonzBUMeasuring respiratory symptoms of COPD: performance of the EXACT- Respiratory Symptoms Tool (E-RS) in three clinical trialsRespir Res20141512425287629
   PubMed Web of Science ®Google Scholar
• JonesPWBrusselleGdal NegroRWProperties of the COPD assessment test in a cross-sectional European studyEur Respir J2011381293521565915
   PubMed Web of Science ®Google Scholar
• BrusselleGPriceDGruffydd-JonesKThe inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UKInt J Chron Obstruct Pulmon Dis2015102207221726527869
   PubMed Web of Science ®Google Scholar
• MiyazakiMNakamuraHTakahashiSThe reasons for triple therapy in stable COPD patients in Japanese clinical practiceInt J Chron Obstruct Pulmon Dis2015101053105926082629
   PubMed Web of Science ®Google Scholar
• KewKMDiasSCatesCJLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisCochrane Database Syst Rev20143CD010844
   PubMed Web of Science ®Google Scholar
• SilerTMKerwinETombsLFahyWANayaITriple therapy of umeclidinium + inhaled corticosteroids/long-acting beta2 agonists for patients with COPD: pooled results of randomized placebo-controlled trialsPulm Ther2016214358
   Google Scholar
• VogelmeierCFBatemanEDPallanteJEfficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyLancet Respir Med201311516024321804
   PubMed Web of Science ®Google Scholar
• SinghDWorsleySZhuCQHardakerLChurchAUmeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trialBMC Pulm Med2015159126286141
   PubMed Web of Science ®Google Scholar